# Prospective Treatment Efficacy in IPF Using Genotype for Nac Selection (PRECISIONS) Trial

> **NCT04300920** · PHASE3 · COMPLETED · sponsor: **Fernando J Martinez** · enrollment: 202 (actual)

## Conditions studied

- Idiopathic Pulmonary Fibrosis

## Interventions

- **DRUG:** N-acetyl cysteine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04300920
- **Lead sponsor:** Fernando J Martinez
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-17
- **Primary completion:** 2026-03-02
- **Final completion:** 2026-03-02
- **Target enrollment:** 202 (ACTUAL)
- **Last updated:** 2026-03-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04300920

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04300920, "Prospective Treatment Efficacy in IPF Using Genotype for Nac Selection (PRECISIONS) Trial". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04300920. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*